Literature DB >> 25550920

Rho-kinase inhibition is involved in the activation of PI3-kinase/Akt during ischemic-preconditioning-induced cardiomyocyte apoptosis.

Juan Zhang1, Xiao-Bo Liu2, Chao Cheng1, Dong-Ling Xu1, Qing-Hua Lu1, Xiao-Ping Ji3.   

Abstract

UNLABELLED: We and others have reported that Rho-kinase plays an important role in the pathogenesis of heart ischemia/reperfusion (I/R) injury. Studies also have demonstrated that the activation of Rho-kinase was reversed in ischemic preconditioning (IPC). This study aimed to explain the mechanism of Rho-kinase-mediated cardiomyocyte apoptosis increased in I/R and reversed in IPC.
MATERIALS AND METHODS: Studies were performed with female Wistar rats. The I/R rats were created by ligating the left anterior descending branch (LAD) for 30 min and releasing the ligature for 180 min. The IPC rats underwent IPC (two cycles of 5 min ligation of the LAD and 5 min reflow) before I/R.
RESULTS: Ischemia followed by reperfusion caused a significant increase in Rho-kinase and a decrease in Akt phosphorylation. Administration of fasudil, an inhibitor of Rho-kinase, decreased myocardial infarction size and cardiomyocyte apoptosis and increased Akt activation. IPC also caused the reduced Rho-kinase activity and cardiomyocyte apoptosis and a significant increase in Akt activity (P<0.05 vs I/R).
CONCLUSION: Rho-kinase inhibition by IPC leads to reduced cardiomyocyte apoptosis may be mediated by activation of PI3-kinase/Akt.

Entities:  

Keywords:  PI3-kinase/Akt; Rho-kinase; apoptosis; heart ischemia/reperfusion; ischemic preconditioning

Year:  2014        PMID: 25550920      PMCID: PMC4276178     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  20 in total

1.  Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase.

Authors:  M Amano; K Chihara; K Kimura; Y Fukata; N Nakamura; Y Matsuura; K Kaibuchi
Journal:  Science       Date:  1997-02-28       Impact factor: 47.728

2.  Ischemic and anesthetic preconditioning reduces cytosolic [Ca2+] and improves Ca(2+) responses in intact hearts.

Authors:  J An; S G Varadarajan; E Novalija; D F Stowe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-10       Impact factor: 4.733

3.  Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.

Authors:  Yi-Xin Wang; Valdeci da Cunha; Baby Martin-McNulty; Jon Vincelette; Weiwei Li; David F Choy; Meredith Halks-Miller; Mithra Mahmoudi; Miriam Schroeder; Anthony Johns; David R Light; William P Dole
Journal:  Eur J Pharmacol       Date:  2005-04-11       Impact factor: 4.432

4.  Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle.

Authors:  Tetsuya Seko; Masaaki Ito; Yasuko Kureishi; Ryuji Okamoto; Nobuyuki Moriki; Katsuya Onishi; Naoki Isaka; David J Hartshorne; Takeshi Nakano
Journal:  Circ Res       Date:  2003-02-06       Impact factor: 17.367

5.  Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection.

Authors:  Sebastian Wolfrum; Andreas Dendorfer; Yoshiyuki Rikitake; Timothy J Stalker; Yulan Gong; Rosario Scalia; Peter Dominiak; James K Liao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-08-19       Impact factor: 8.311

6.  Effects of phytoestrogen genistein on myocardial ischemia/reperfusion injury and apoptosis in rabbits.

Authors:  En-sheng Ji; Hua Yue; Yu-ming Wu; Rui-rong He
Journal:  Acta Pharmacol Sin       Date:  2004-03       Impact factor: 6.150

7.  Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells.

Authors:  Xiu-Fen Ming; Hema Viswambharan; Christine Barandier; Jean Ruffieux; Kozo Kaibuchi; Sandro Rusconi; Zhihong Yang
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

8.  Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury.

Authors:  Weike Bao; Erding Hu; Ling Tao; Rogely Boyce; Rosanna Mirabile; Douglas T Thudium; Xin-ling Ma; Robert N Willette; Tian-li Yue
Journal:  Cardiovasc Res       Date:  2004-02-15       Impact factor: 10.787

9.  Inhibition of the activity of Rho-kinase reduces cardiomyocyte apoptosis in heart ischemia/reperfusion via suppressing JNK-mediated AIF translocation.

Authors:  Juan Zhang; Xiao-Xing Li; Hong-Jun Bian; Xiao-Bo Liu; Xiao-Ping Ji; Yun Zhang
Journal:  Clin Chim Acta       Date:  2008-11-24       Impact factor: 3.786

10.  Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice.

Authors:  Ziad Mallat; Andrea Gojova; Vincent Sauzeau; Valérie Brun; Jean-Sébastien Silvestre; Bruno Esposito; Régine Merval; Hervé Groux; Gervaise Loirand; Alain Tedgui
Journal:  Circ Res       Date:  2003-10-02       Impact factor: 17.367

View more
  8 in total

Review 1.  Diabetes abolish cardioprotective effects of remote ischemic conditioning: evidences and possible mechanisms.

Authors:  Sakshi Tyagi; Nirmal Singh; Jasleen Kaur Virdi; Amteshwar Singh Jaggi
Journal:  J Physiol Biochem       Date:  2019-02-07       Impact factor: 4.158

2.  Sirtinol abrogates late phase of cardiac ischemia preconditioning in rats.

Authors:  Fereshteh Safari; Shahnaz Shekarforoosh; Tahmineh Hashemi; Simin Namvar Aghdash; Asefeh Fekri; Fatemeh Safari
Journal:  J Physiol Sci       Date:  2016-09-27       Impact factor: 2.781

3.  Effects of vitrification and a Rho-associated coiled-coil containing protein kinase 1 inhibitor on the meiotic and developmental competence of feline oocytes.

Authors:  Saengtawan Arayatham; Narong Tiptanavattana; Theerawat Tharasanit
Journal:  J Reprod Dev       Date:  2017-08-11       Impact factor: 2.214

4.  RhoA inhibits the hypoxia-induced apoptosis and mitochondrial dysfunction in chondrocytes via positively regulating the CREB phosphorylation.

Authors:  Kai Zhang; Dianming Jiang
Journal:  Biosci Rep       Date:  2017-04-20       Impact factor: 3.840

5.  Remote ischemic post-conditioning protects against myocardial ischemia/reperfusion injury by inhibiting the Rho-kinase signaling pathway.

Authors:  Feng Min; Xian Jie Jia; Qin Gao; Fang Niu; Zhi Yuan Hu; Ya Ling Han; Hong Jie Shi; Ying Yu
Journal:  Exp Ther Med       Date:  2019-11-08       Impact factor: 2.447

6.  The combination approach with Rhokinase inhibition and mechanical circulatory support in myocardial ischemia-reperfusion injury: Rho-kinase inhibition and ventricular unloading.

Authors:  Shunsuke Miyahara; Alexander Jenke; Mariam Yazdanyar; Julia Kistner; Moritz Benjamin Immohr; Yukiharu Sugimura; Hug Aubin; Hiroyuki Kamiya; Yutaka Okita; Artur Lichtenberg; Payam Akhyari
Journal:  Asian Cardiovasc Thorac Ann       Date:  2022-07-15

7.  Penehyclidine Hydrochloride Preconditioning Provides Cardioprotection in a Rat Model of Myocardial Ischemia/Reperfusion Injury.

Authors:  Duomao Lin; Jun Ma; Yanyan Xue; Zhaoqi Wang
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

8.  Investigating the role of acute and repeated stress on remote ischemic preconditioning-induced cardioprotection.

Authors:  Sakshi Tyagi; Simranjot Kaur; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Iran J Basic Med Sci       Date:  2020-01       Impact factor: 2.699

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.